Bruce Brady
Endocrinology, Diabetes & Metabolism · Salt Lake City, UTNPI 1467474676
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 342 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,016 and has fallen 90.9% since, to $184 in 2022.
Across 342 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$515
- Merck$486
- Boehringer Ingelheim$434
- Novo Nordisk$414
- Antares Pharma, Inc.$355
- Abbott$349
- plus $3K from 25 others
What the payments were for
- Food & beverage$5,07499%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 26 | $515 |
| Merck | 31 | $486 |
| Boehringer Ingelheim | 25 | $434 |
| Novo Nordisk | 36 | $414 |
| Antares Pharma, Inc. | 26 | $355 |
| Abbott | 30 | $349 |
| AbbVie | 20 | $290 |
| Lilly USA, LLC | 18 | $237 |
| Xeris Pharmaceuticals, Inc. | 11 | $212 |
| Radius Health, Inc. | 13 | $200 |
| Insulet Corporation | 14 | $181 |
| Johnson & Johnson | 15 | $176 |
| Sanofi-aventis U.S. LLC | 12 | $170 |
| Medtronic(2 entities) | 12 | $164 |
| Corcept Therapeutics | 10 | $154 |
| Bayer | 1 | $125 |
| Dexcom, Inc. | 8 | $122 |
| Amgen | 6 | $109 |
| Tandem Diabetes Care, Inc. | 4 | $77 |
| Amarin Pharma, Inc. | 5 | $70 |
| Regeneron Healthcare Solutions, Inc. | 4 | $59 |
| Mannkind Corporation | 3 | $43 |
| Vistapharm, Inc. | 3 | $43 |
| Lifescan, Inc. | 2 | $30 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| IBSA Pharma Inc. | 1 | $19 |
| BD | 1 | $17 |
| Rhythm Pharmaceuticals, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Zealand Pharma US, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$125
How this compares
$5,124 in reported general payments places this provider in the 55th percentile of 38 endocrinology, diabetes & metabolism providers in Utah.
See all endocrinology, diabetes & metabolism providers in Utah →
Other endocrinology, diabetes & metabolism in Salt Lake City
- Eliot BrintonSalt Lake City$733K
- Alireza Falahati-NiniSalt Lake City$241K
- Shahzad AhmadSalt Lake City$25K
- Vishnu SundareshSalt Lake City$18K
- Barry BenowitzSalt Lake City$4K
- Marie CouldwellSalt Lake City$3K
- Kelsey DesalvoSalt Lake City$3K
- Sneha WagleSalt Lake City$257
- Javier Munoz BarreraSalt Lake City$160
- Ross HeinrichSalt Lake City$122
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.